WO1998016636A1
(fr)
*
|
1996-10-17 |
1998-04-23 |
Mitsubishi Chemical Corporation |
Molecule permettant d'homologuer un genotype et un phenotype, et utilisation de celle-ci
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
WO1999051773A1
(en)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
US6416950B1
(en)
*
|
1998-12-02 |
2002-07-09 |
Phylos, Inc. |
DNA-protein fusions and uses thereof
|
US7115396B2
(en)
*
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
US6623926B1
(en)
|
1999-06-01 |
2003-09-23 |
Phylos, Inc. |
Methods for producing 5′-nucleic acid-protein conjugates
|
ES2383332T3
(es)
*
|
1999-07-27 |
2012-06-20 |
Bristol-Myers Squibb Company |
Procedimiento de ligación de aceptores de péptidos
|
EP1212452B1
(en)
|
1999-08-27 |
2013-07-17 |
Bristol-Myers Squibb Company |
Methods for encoding and sorting in vitro translated proteins
|
EP1250463B1
(en)
*
|
2000-01-24 |
2006-04-05 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
JP2003523756A
(ja)
*
|
2000-02-24 |
2003-08-12 |
フィロス インク. |
触媒蛋白質の生成のための改良された方法
|
US6962781B1
(en)
|
2000-05-19 |
2005-11-08 |
Proteonova, Inc. |
In vitro evolution of nucleic acids and encoded polypeptide
|
US20040229271A1
(en)
*
|
2000-05-19 |
2004-11-18 |
Williams Richard B. |
Compositions and methods for the identification and selection of nucleic acids and polypeptides
|
US7410761B2
(en)
*
|
2000-05-19 |
2008-08-12 |
Proteonova, Inc. |
System for rapid identification and selection of nucleic acids and polypeptides, and method thereof
|
JP4963142B2
(ja)
*
|
2000-12-14 |
2012-06-27 |
学校法人慶應義塾 |
遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法
|
US7273923B2
(en)
|
2001-01-22 |
2007-09-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
ATE335754T1
(de)
|
2001-03-19 |
2006-09-15 |
Harvard College |
Entwicklung neuer molekularer funktionen
|
EP1401850A1
(en)
|
2001-06-20 |
2004-03-31 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
WO2002103008A2
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Templated molecules and methods for using such molecules
|
WO2004001042A2
(en)
*
|
2002-06-20 |
2003-12-31 |
Nuevolution A/S |
Microarrays displaying encoded molecules
|
EP1419274A4
(en)
*
|
2001-07-31 |
2006-02-08 |
Phylos Inc |
MODULAR CONSTRUCTION OF NUCLEIC ACID PROTEIN FUSION MULTIMERS
|
DE10145226A1
(de)
*
|
2001-09-13 |
2003-04-10 |
Lifebits Ag |
Herstellung von trägergebundenen Molekülen
|
AU2002356984A1
(en)
*
|
2001-11-16 |
2003-06-10 |
Proteonova, Inc. |
Selection and evolution of nucleic acids and polypeptides
|
WO2003045975A2
(en)
*
|
2001-11-27 |
2003-06-05 |
Compound Therapeutics, Inc. |
Solid-phase immobilization of proteins and peptides
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
WO2009095742A1
(en)
|
2008-01-31 |
2009-08-06 |
Cellectis |
New i-crei derived single-chain meganuclease and uses thereof
|
CN101006177B
(zh)
|
2002-03-15 |
2011-10-12 |
纽韦卢森公司 |
改善的用于合成模制分子的方法
|
EP1504111A4
(en)
*
|
2002-04-19 |
2005-11-23 |
California Inst Of Techn |
PEPTIDES NUCLEIC ACID PEPTIDE DISPLAY LIBRARS CONTAINING UNNATURELY AMINO-ACID-RESISTANT AND METHOD FOR THE PRODUCTION THEREOF
|
US20030198973A1
(en)
*
|
2002-04-23 |
2003-10-23 |
The Molecular Sciences Institute, Inc. |
Chimeric fusion molecule for analyte detection and quantitation
|
US20060073481A1
(en)
*
|
2002-04-23 |
2006-04-06 |
The Molecular Sciences Institute |
Formation and use of site specific nucleic acid coupled binding polypeptides
|
US10730906B2
(en)
|
2002-08-01 |
2020-08-04 |
Nuevolutions A/S |
Multi-step synthesis of templated molecules
|
JP4657919B2
(ja)
|
2002-08-19 |
2011-03-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
進化する新しい分子機能
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
ES2640279T3
(es)
|
2002-10-30 |
2017-11-02 |
Nuevolution A/S |
Procedimiento para la síntesis de un complejo bifuncional
|
US9121110B2
(en)
|
2002-12-19 |
2015-09-01 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
AU2004208031B2
(en)
|
2003-01-28 |
2009-10-08 |
Cellectis |
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
|
WO2004074429A2
(en)
|
2003-02-21 |
2004-09-02 |
Nuevolution A/S |
Method for producing second-generation library
|
DK2236606T3
(da)
|
2003-03-20 |
2014-02-10 |
Nuevolution As |
Kodning af små molekyler ved ligering
|
DE602004023960D1
(de)
|
2003-09-18 |
2009-12-17 |
Nuevolution As |
Methode zur Gewinnung struktureller Informationen kodierter Moleküle und zur Selektion von Verbindungen
|
KR20060129246A
(ko)
|
2003-12-05 |
2006-12-15 |
컴파운드 쎄라퓨틱스, 인크. |
타입 2 혈관 내피 성장 인자 수용체의 억제제
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
US20050191662A1
(en)
*
|
2003-12-22 |
2005-09-01 |
Syngenta Participations Ag |
In vitro screening and evolution of proteins
|
DK1730277T3
(da)
|
2004-03-22 |
2010-03-01 |
Nuevolution As |
Kodning ved ligering under anvendelse af byggebloksoligonukleotider
|
US20090258348A1
(en)
*
|
2005-02-02 |
2009-10-15 |
Universität Bayreuth |
Esterases for monitoring protein biosynthesis in vitro
|
WO2007011722A2
(en)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Reaction discovery system
|
EP1785434A1
(en)
|
2005-11-11 |
2007-05-16 |
Ludwig-Maximilians-Universität München |
Targeting and tracing of antigens in living cells
|
EP2339014B1
(en)
|
2005-11-16 |
2015-05-27 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
SI2341140T1
(sl)
|
2005-12-01 |
2017-12-29 |
Nuevolution A/S |
Postopki encimskega kodiranja za učinkovito sintezo velikih knjižnic
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
EP2044219B1
(en)
|
2006-06-30 |
2013-05-22 |
DiscoveRx Corporation |
Detectable nucleic acid tag
|
CA2670471A1
(en)
|
2006-11-22 |
2008-06-05 |
Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
|
US20100144599A1
(en)
|
2007-02-02 |
2010-06-10 |
Bristol-Myers Squibb Company |
Vegf pathway blockade
|
US7678883B2
(en)
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
AU2008287426B2
(en)
*
|
2007-08-10 |
2014-06-26 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
US8680019B2
(en)
*
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
US8691730B2
(en)
|
2007-09-14 |
2014-04-08 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
DK2567709T3
(en)
|
2007-11-02 |
2018-03-12 |
Novartis Ag |
Molecules and Methods for Modulating Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6)
|
NZ602498A
(en)
|
2007-11-30 |
2014-08-29 |
Abbvie Inc |
Protein formulations and methods of making same
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
JP2011517314A
(ja)
|
2008-02-14 |
2011-06-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
Egfrに結合する操作されたタンパク質に基づく標的化された治療薬
|
EP2799448A1
(en)
|
2008-05-22 |
2014-11-05 |
Bristol-Myers Squibb Company |
Multivalent fibronectin based scaffold domain proteins
|
EP3629022A1
(en)
|
2008-07-25 |
2020-04-01 |
Richard W. Wagner |
Protein screening methods
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之egfr/igfir結合分子
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158822A1
(en)
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
JP2012522057A
(ja)
*
|
2009-03-30 |
2012-09-20 |
ジヨンソン・アンド・ジヨンソン・コンシユーマー・カンパニーズ・インコーポレーテツド |
化粧用剤の送達のためのペプチドに基づく系
|
US8481678B2
(en)
|
2009-03-30 |
2013-07-09 |
E I Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
US9085798B2
(en)
|
2009-04-30 |
2015-07-21 |
Prognosys Biosciences, Inc. |
Nucleic acid constructs and methods of use
|
EP2492344B1
(en)
|
2009-10-22 |
2016-04-06 |
PeptiDream Inc. |
Rapid display method in translational synthesis of peptide
|
ES2691717T3
(es)
|
2009-10-30 |
2018-11-28 |
Novartis Ag |
Bibliotecas universales del dominio de unión del lado inferior de tipo iii de la fibronectina de tipo III
|
JP2013509869A
(ja)
|
2009-11-05 |
2013-03-21 |
ノバルティス アーゲー |
線維症の進行の予測用バイオマーカー
|
CA2789125A1
(en)
|
2010-02-10 |
2011-08-18 |
Novartis Ag |
Methods and compounds for muscle growth
|
AU2011218243A1
(en)
|
2010-02-18 |
2012-10-04 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind IL-23
|
PL2556171T3
(pl)
|
2010-04-05 |
2016-04-29 |
Prognosys Biosciences Inc |
Oznaczenia biologiczne kodowane przestrzennie
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
EP2556086B1
(en)
|
2010-04-09 |
2015-03-04 |
Amgen Inc. |
Btnl9 proteins, nucleic acids, and antibodies and uses thereof
|
DK2558491T3
(en)
|
2010-04-13 |
2018-10-15 |
Bristol Myers Squibb Co |
Fibronectin-based Scaffold domain proteins that bind PCSK9
|
LT2558577T
(lt)
|
2010-04-16 |
2019-03-12 |
Nuevolution A/S |
Bifunkciniai kompleksai ir tokių kompleksų gamybos ir naudojimo būdai
|
KR101863033B1
(ko)
*
|
2010-04-30 |
2018-06-01 |
얀센 바이오테크 인코포레이티드 |
안정화된 파이브로넥틴 도메인 조성물, 방법 및 용도
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
JP6023703B2
(ja)
|
2010-05-26 |
2016-11-09 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
改善された安定性を有するフィブロネクチンをベースとする足場タンパク質
|
HUE037359T2
(hu)
*
|
2010-07-09 |
2018-08-28 |
Cergentis B V |
A fontos V3-D genom-régió szekvenálási stratégiái
|
CN105734678B
(zh)
|
2010-07-16 |
2019-11-05 |
阿迪马布有限责任公司 |
合成多核苷酸文库
|
JP6092773B2
(ja)
|
2010-07-30 |
2017-03-08 |
ノバルティス アーゲー |
フィブロネクチンクレードル分子及びそのライブラリ
|
KR102057438B1
(ko)
|
2010-11-05 |
2019-12-20 |
에이자이 아이엔씨. |
엽산 수용체 알파-발현 암에 대한 진단 및 예후 마커로서의 엽산 수용체 알파
|
WO2012074130A1
(ja)
*
|
2010-12-03 |
2012-06-07 |
国立大学法人東京大学 |
ペプチドライブラリーの製造方法、ペプチドライブラリー、及びスクリーニング方法
|
US9260496B2
(en)
|
2010-12-22 |
2016-02-16 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind IL-23
|
DE102010056289A1
(de)
|
2010-12-24 |
2012-06-28 |
Geneart Ag |
Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
|
US9746475B2
(en)
|
2011-03-14 |
2017-08-29 |
University Of Southern California |
Antibody and antibody mimetic for visualization and ablation of endogenous proteins
|
ES2926988T3
(es)
|
2011-03-15 |
2022-10-31 |
X Body Inc |
Métodos de cribado de anticuerpos
|
US20120258871A1
(en)
|
2011-04-08 |
2012-10-11 |
Prognosys Biosciences, Inc. |
Peptide constructs and assay systems
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
EP3415528B1
(en)
|
2011-04-13 |
2021-05-26 |
Bristol-Myers Squibb Company |
Fc fusion proteins comprising novel linkers or arrangements
|
EP3421592B1
(en)
|
2011-04-28 |
2023-09-13 |
The Board of Trustees of the Leland Stanford Junior University |
Identification of polynucleotides associated with a sample
|
ES2848531T3
(es)
|
2011-05-17 |
2021-08-10 |
Bristol Myers Squibb Co |
Métodos mejorados para la selección de proteínas de unión
|
US20140187488A1
(en)
|
2011-05-17 |
2014-07-03 |
Bristol-Myers Squibb Company |
Methods for maintaining pegylation of polypeptides
|
US20140369934A1
(en)
|
2011-06-02 |
2014-12-18 |
Massachusetts Institute Of Technology |
dsRNA/DNA Hybrid Genome Replication Intermediate Of Metakaryotic Stem Cells
|
WO2013019794A1
(en)
|
2011-08-01 |
2013-02-07 |
The General Hospital Corporation |
Protein and peptide libraries
|
US20140234903A1
(en)
|
2011-09-05 |
2014-08-21 |
Eth Zurich |
Biosynthetic gene cluster for the production of peptide/protein analogues
|
CN104053670A
(zh)
|
2011-10-31 |
2014-09-17 |
百时美施贵宝公司 |
具有降低的免疫原性的纤连蛋白结合域
|
TWI640537B
(zh)
|
2011-12-05 |
2018-11-11 |
X 染色體有限公司 |
PDGF受體β結合多肽
|
ES2755104T3
(es)
|
2012-05-17 |
2020-04-21 |
Ra Pharmaceuticals Inc |
Inhibidores peptídicos y peptidomiméticos
|
EP2875046B1
(en)
|
2012-07-19 |
2020-02-26 |
Amgen Inc. |
Human btnl3 proteins, nucleic acids, and antibodies and uses thereof
|
ES2727453T3
(es)
|
2012-09-13 |
2019-10-16 |
Bristol Myers Squibb Co |
Proteínas de dominio de armazón a base de fibronectina que se unen a miostatina
|
EP2952582A4
(en)
*
|
2013-01-30 |
2016-11-16 |
Peptidream Inc |
FLEXIBLE DISPLAY METHOD
|
US20150361159A1
(en)
|
2013-02-01 |
2015-12-17 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins
|
WO2014133855A1
(en)
|
2013-02-28 |
2014-09-04 |
Caprion Proteomics Inc. |
Tuberculosis biomarkers and uses thereof
|
EP2968587A2
(en)
|
2013-03-13 |
2016-01-20 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
|
US10132816B2
(en)
|
2013-03-14 |
2018-11-20 |
Beth Israel Deaconess Medical Center, Inc. |
Measurement of FGF21 as a biomarker of fructose metabolism
|
US9938523B2
(en)
*
|
2013-03-15 |
2018-04-10 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling
|
CN105358984B
(zh)
|
2013-03-15 |
2020-02-18 |
普罗格诺西斯生物科学公司 |
用于检测肽/mhc/tcr结合的方法
|
EP3567123B1
(en)
|
2013-05-20 |
2021-11-10 |
BioVentures, LLC |
Gep5 model for multiple myeloma
|
CN118240918A
(zh)
|
2013-06-25 |
2024-06-25 |
普罗格诺西斯生物科学公司 |
采用微流控装置的空间编码生物分析
|
SG10201806428YA
(en)
|
2013-06-28 |
2018-08-30 |
X Body Inc |
Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
|
EP3049811B1
(en)
|
2013-09-23 |
2020-09-09 |
X-Body, Inc. |
Methods and compositions for generation of binding agents against cell surface antigens
|
WO2015070037A2
(en)
|
2013-11-08 |
2015-05-14 |
Prognosys Biosciences, Inc. |
Polynucleotide conjugates and methods for analyte detection
|
GB201322692D0
(en)
|
2013-12-20 |
2014-02-05 |
Philochem Ag |
Production of encoded chemical libraries
|
EP3102245B1
(en)
|
2014-02-05 |
2021-09-08 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
JP6591437B2
(ja)
|
2014-03-20 |
2019-10-16 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
血清アルブミン結合フィブロネクチンiii型ドメイン
|
MX371403B
(es)
|
2014-03-20 |
2020-01-29 |
Bristol Myers Squibb Co |
Moleculas de andamiaje a base de fibronectina estabilizada.
|
NZ727420A
(en)
|
2014-06-12 |
2018-06-29 |
Ra Pharmaceuticals Inc |
Modulation of complement activity
|
CN114057857A
(zh)
|
2014-06-20 |
2022-02-18 |
豪夫迈·罗氏有限公司 |
基于chagasin的支架组合物、方法和应用
|
CN107207379B
(zh)
|
2014-11-25 |
2021-08-10 |
百时美施贵宝公司 |
用于生物制品的18f-放射性标记的方法和组合物
|
EP3224277B1
(en)
|
2014-11-25 |
2020-08-26 |
Bristol-Myers Squibb Company |
Novel pd-l1 binding polypeptides for imaging
|
PT3250230T
(pt)
|
2015-01-28 |
2021-12-07 |
Ra Pharmaceuticals Inc |
Moduladores da atividade do complemento
|
EP3061826A1
(en)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus replicons
|
WO2016134521A1
(en)
|
2015-02-27 |
2016-09-01 |
The University Of Hong Kong |
Dna display and methods thereof
|
EP4119677B1
(en)
|
2015-04-10 |
2023-06-28 |
Spatial Transcriptomics AB |
Spatially distinguished, multiplex nucleic acid analysis of biological specimens
|
WO2016164708A1
(en)
|
2015-04-10 |
2016-10-13 |
Adimab, Llc |
Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species
|
PT3286212T
(pt)
|
2015-04-24 |
2021-08-24 |
Viiv Healthcare Uk No 5 Ltd |
Polipéptidos dirigidos para fusão com hiv
|
KR20240093813A
(ko)
|
2015-04-24 |
2024-06-24 |
제넨테크, 인크. |
다중특이적 항원-결합 단백질
|
JP6951340B2
(ja)
|
2015-09-23 |
2021-10-20 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
グリピカン−3結合フィブロネクチンベース足場分子
|
US10766946B2
(en)
|
2015-09-23 |
2020-09-08 |
Bristol-Myers Squibb Company |
Fast-off rate serum albumin binding fibronectin type III domains
|
EP3389692B1
(en)
|
2015-12-16 |
2020-03-04 |
RA Pharmaceuticals, Inc. |
Modulators of complement activity
|
EP3433275A1
(en)
|
2016-03-24 |
2019-01-30 |
Millennium Pharmaceuticals, Inc. |
Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
|
TW201735949A
(zh)
|
2016-03-24 |
2017-10-16 |
千禧製藥公司 |
治療抗ctla4及抗pd-1組合治療中的胃腸道免疫相關不良事件之方法
|
AU2017240164A1
(en)
*
|
2016-04-01 |
2018-11-15 |
HealthTell, Inc. |
Array-based peptide libraries for therapeutic antibody characterization
|
US20190284249A1
(en)
*
|
2016-04-25 |
2019-09-19 |
Evorx Technologies, Inc. |
Beta-catenin barcoded peptides
|
US10994033B2
(en)
|
2016-06-01 |
2021-05-04 |
Bristol-Myers Squibb Company |
Imaging methods using 18F-radiolabeled biologics
|
KR102397783B1
(ko)
|
2016-06-01 |
2022-05-12 |
브리스톨-마이어스 스큅 컴퍼니 |
Pd-l1 결합 폴리펩티드에 의한 pet 영상화
|
CA3028002A1
(en)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
WO2018089556A1
(en)
|
2016-11-09 |
2018-05-17 |
Healthtell Inc. |
Coatings with tunable amine density
|
US11123399B2
(en)
|
2016-12-07 |
2021-09-21 |
Ra Pharmaceuticals, Inc. |
Modulators of complement activity
|
EP3597746B1
(en)
*
|
2017-03-17 |
2023-04-19 |
Cubicstars, Inc. |
Method for producing complex of rna molecule and peptide, and utilization thereof
|
WO2019123262A1
(en)
|
2017-12-18 |
2019-06-27 |
VIIV Healthcare UK (No.5) Limited |
Antigen binding polypeptides
|
EP3775261A4
(en)
|
2018-03-26 |
2021-11-24 |
Rootpath Genomics, Inc. |
COMPOSITIONS OF TARGET UNITS AND METHODS OF USE
|
US20220064630A1
(en)
|
2018-12-10 |
2022-03-03 |
10X Genomics, Inc. |
Resolving spatial arrays using deconvolution
|
NZ782502A
(en)
*
|
2019-02-15 |
2023-10-27 |
Atreca Inc |
Antibodies that bind tumor tissue, and their diagnostic and therapeutic uses
|
CN110777158B
(zh)
*
|
2019-03-13 |
2022-01-21 |
深圳市臻质医疗科技有限公司 |
一种DNA片段、具有细胞特异性结合能力的mRNA-抗体融合分子及其制备方法
|
EP3966244A1
(en)
|
2019-05-09 |
2022-03-16 |
F. Hoffmann-La Roche AG |
Methods of making antibodies
|
WO2021174045A1
(en)
|
2020-02-28 |
2021-09-02 |
Bristol-Myers Squibb Company |
Radiolabeled fibronectin based scaffolds and antibodies and theranostic uses thereof
|
CN112851771A
(zh)
*
|
2021-02-09 |
2021-05-28 |
中国科学院武汉病毒研究所 |
连接核酸与蛋白或肽的方法
|